PT-141 (Bremelanotide): Melanocortin Receptor Research Guide PT-141 (Bremelanotide) is a cyclic heptapeptide derived from Melanotan II, modified to remove MC1R activity and concentrate action at the central MC3R and MC4R receptors
GHK-Cu has been integrated into topical formulations that purportedly accelerate wound healing, enhance suppleness, and normalize pigmentation
Pricing, eligibility, and program terms can change - verify current terms on mademed.com

If you develop a mild rash whilst taking Rybelsus, there are several practical measures that may help whilst awaiting medical assessment: General skin care measures: Keep the affected area clean and dry Avoid scratching, which can worsen irritation and risk infection Wear loose, breathable cotton clothing to minimise friction Use fragrance-free, hypoallergenic moisturisers to maintain skin barrier function Avoid hot baths or showers, which can exacerbate itching Consider cool compresses for symptomatic relief Over-the-counter options (after consulting a pharmacist): Oral antihistamines (such as cetirizine or loratadine) may help with itching Mild topical corticosteroids (such as hydrocortisone 1% cream) for localised inflammation - use for a maximum of 7 days, avoid applying to the face, genitals, broken or infected skin, and follow age restrictions on the packaging [19] [20] Emollients to soothe dry or irritated skin Your healthcare professional will conduct a thorough assessment to determine the cause of the rash and whether it is appropriate to continue Rybelsus

AMOSO Opportunities fund to LP